Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/19/2025 | PUT | $33.50 | 434 | +407 | +1,507.41% |
| 12/26/2025 | PUT | $37.50 | 329 | +327 | +16,350.00% |
| 12/12/2025 | CALL | $42.00 | 860 | +317 | +58.38% |
| 12/12/2025 | CALL | $40.00 | 2,503 | +294 | +13.31% |
| 01/15/2027 | CALL | $40.00 | 3,560 | +199 | +5.92% |
| 12/19/2025 | PUT | $30.00 | 1,179 | +175 | +17.43% |
| 12/12/2025 | PUT | $34.00 | 880 | -15 | -1.68% |
| 02/20/2026 | CALL | $30.00 | 728 | -15 | -2.02% |
| 12/19/2025 | CALL | $35.00 | 2,170 | -20 | -0.91% |
| 01/16/2026 | CALL | $80.00 | 2,524 | -20 | -0.79% |
| 12/12/2025 | CALL | $38.00 | 331 | -24 | -6.76% |
| 01/16/2026 | CALL | $100.00 | 5,305 | -200 | -3.63% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.85% | 2.23M | 34.34M |
| Vanguard Extended Market Index Fund | 1.22% | 953.28k | 14.67M |
| Fidelity Advisor Biotechnology Fund | 1.21% | 947.5k | 14.58M |
| Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 0.70% | 548.41k | 8.44M |
| Fidelity Extended Market Index Fund | 0.45% | 350.41k | 5.39M |
| Delaware Group Equity Fds IV-Delaware Healthcare Fund | 0.42% | 330.1k | 5.08M |
| DFA U.S. Targeted Value Portfolio | 0.22% | 171.27k | 2.64M |
| iShares Micro Cap ETF | 0.19% | 147.28k | 2.27M |
| Fidelity Total Market Index Fund | 0.15% | 119.66k | 1.84M |
| Dimensional ETF Tr-Dimensional U.S. Targeted Value ETF | 0.15% | 116.61k | 1.79M |
2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole
12/13 11:15 am
The Motley Fool
Read moreMy Top 10 Stocks to Buy for 2026
12/13 05:10 am
The Motley Fool
Read more3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026
12/11 08:15 am
The Motley Fool
Read moreWhat's Happening With French Biotech Abivax Stock On Wednesday?
12/10 01:42 pm
Benzinga
Read morePrediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029
11/27 09:15 am
The Motley Fool
Read moreViking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
11/25 05:05 pm
Benzinga
Read more2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon
11/22 10:20 am
The Motley Fool
Read moreMissed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
11/19 07:05 am
The Motley Fool
Read more5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
11/18 03:11 pm
The Motley Fool
Read moreBillionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets.
11/04 09:10 pm
The Motley Fool
Read moreViking Therapeutics to Participate at Upcoming Investor Conferences
11/04 05:05 pm
Benzinga
Read moreShould You Buy Viking Therapeutics Before Nov. 5?
11/02 10:20 am
The Motley Fool
Read moreViking Therapeutics: High Risk, High Reward Play
10/27 11:12 am
Investing.com
Read moreViking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025
10/15 04:05 pm
Benzinga
Read moreDown 44%, Should You Buy the Dip on Viking Therapeutics?
10/13 10:15 am
The Motley Fool
Read moreThe Best Stocks to Invest $1,000 in Right Now
10/05 04:31 pm
The Motley Fool
Read moreWhy This Beaten-Down GLP-1 Stock Could Be a Steal
09/30 09:15 am
The Motley Fool
Read moreBiotech Breakouts: 3 Stocks With Massive Upside Potential
09/18 07:05 am
Investing.com
Read moreHere Is My Top Stock Pick Among the Weight Loss Industry Leaders
09/16 03:15 am
The Motley Fool
Read moreThis Under-the-Radar Healthcare Stock Could Soar in 2026
09/12 08:15 am
The Motley Fool
Read moreThink It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.
09/07 11:14 am
The Motley Fool
Read moreDown 34%, Should You Buy the Dip on Viking Therapeutics?
09/05 04:10 am
The Motley Fool
Read more2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
08/29 04:26 am
The Motley Fool
Read moreViking Therapeutics to Participate at Upcoming Investor Conferences
08/28 04:30 pm
Benzinga
Read moreWhy Is Viking Therapeutics Stock Crashing, and Is It a Buying Opportunity?
08/27 07:30 am
The Motley Fool
Read moreViking Therapeutics: What's Next?
08/26 06:15 am
The Motley Fool
Read moreIs Beaten-Down Viking Therapeutics Stock a Buy on the Dip?
08/21 05:24 am
The Motley Fool
Read moreViking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme'
08/19 02:44 pm
Benzinga
Read moreWhy Novo Nordisk Stock Popped Today
08/19 11:24 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Crashed Today
08/19 11:16 am
The Motley Fool
Read moreLike Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks
08/19 09:28 am
Benzinga
Read moreEli Lilly Considering Viking Therapeutics Acquisition? Expert Says 'They're Setting Up For Something BIG' As LLY Issues 40-Year Bond
08/19 02:12 am
Benzinga
Read morePredicting the Next Rule Breaker Buyout
08/19 12:08 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Zoomed 5% Higher Today
08/18 06:18 pm
The Motley Fool
Read moreThis Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors
08/17 07:15 am
The Motley Fool
Read moreIf You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
08/12 10:26 am
The Motley Fool
Read moreIs It Time to Buy Biotech Stocks?
08/06 04:28 pm
The Motley Fool
Read moreThis Biotech Stock Could Soar on Upcoming Clinical Data
08/04 07:15 am
The Motley Fool
Read more2 Beaten-Down Stocks With Incredible Upside Potential
08/03 12:32 pm
The Motley Fool
Read moreBetter Growth Buy: Eli Lilly vs. Viking Therapeutics
07/22 07:15 am
The Motley Fool
Read more3 Monster Stocks in the Making to Buy Right Now
07/21 12:07 am
The Motley Fool
Read moreAfter Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
07/19 06:09 am
The Motley Fool
Read moreWhy I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
07/04 04:30 am
The Motley Fool
Read more3 Growth Stocks I'm Loading Up On
06/26 05:15 am
The Motley Fool
Read more3 Best Growth Stocks to Buy in June
06/02 06:15 am
The Motley Fool
Read moreViking Therapeutics to Participate at Upcoming Investor Conferences
05/28 04:05 pm
Benzinga
Read moreBetter Weight Loss Stock: Amgen or Viking Therapeutics?
05/22 11:05 am
The Motley Fool
Read more